Skip to content
LAB·Nasdaq·US

Standard BioTools

Standard BioTools develops and sells life-science instrumentation, consumables, and related workflow solutions for high-dimensional biological analysis. The company serves research and applied markets with products used for single-cell, proteomic, and other multiomics applications.

Recent Activity

Updated Oct 3, 2026
–Standard BioTools entered into a new purchase agreement with Element Biosystems, a subsidiary of GMT Venture, for the sale of its mass cytometry business.

Past updates are part of the Pro plan.

Thematic Position

LAB

Relationship Groups

Suppliers2
Partners1
Licensing1
Competitors6

Relationship details are part of the Pro plan.

Ended Relationships

4 ended relationships · Ended relationships are part of the Pro plan.

Management Perspective on Regulatory & Geopolitical Developments

export controldomestic manufacturing requirementmarch-in rights
U.S. government march-in rights over IFC technology developed with federal grants
SEC 10-KMar 16, 2026

The full regulatory passage is part of the Pro plan.

11 more · Regulatory and geopolitical insights are part of the Pro plan.